Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis
Abstract Purpose To evaluate the safety, efficacy, and long-term outcome of bronchial artery embolization (BAE) in the treatment of non-massive hemoptysis and the prognostic factors associated with recurrent bleeding. Materials and methods From March 2005 to September 2014, BAE was performed in 233...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-08-01
|
| Series: | Respiratory Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12931-021-01820-x |
| _version_ | 1831630015274418176 |
|---|---|
| author | Jung Han Hwang Jeong Ho Kim Suyoung Park Ki Hyun Lee So Hyun Park |
| author_facet | Jung Han Hwang Jeong Ho Kim Suyoung Park Ki Hyun Lee So Hyun Park |
| author_sort | Jung Han Hwang |
| collection | DOAJ |
| description | Abstract Purpose To evaluate the safety, efficacy, and long-term outcome of bronchial artery embolization (BAE) in the treatment of non-massive hemoptysis and the prognostic factors associated with recurrent bleeding. Materials and methods From March 2005 to September 2014, BAE was performed in 233 patients with non-massive hemoptysis. All patients had a history of persistent or recurrent hemoptysis despite conservative medical treatment. We assessed the technical and clinical success, recurrence, prognostic factors related to recurrent bleeding, recurrence-free survival rate, additional treatment, and major complications in all the patients. Results Technical success was achieved in 224 patients (96.1%), and clinical success was obtained in 219 (94.0%) of the 233 patients. In addition, 64 patients (27.5%) presented hemoptysis recurrence with median time of 197 days after embolization. Tuberculosis sequelae and presence of aberrant bronchial artery or non-bronchial systemic collaterals were significantly related to recurrent bleeding (p < 0.05). The use of Histoacryl-based embolic materials significantly reduced the recurrent bleeding rate (p < 0.05). Patient who had a tuberculosis sequelae showed a significantly lower recurrence-free survival rate (p = 0.013). Presence of aberrant bronchial artery or non-bronchial systemic collaterals showed a statistically significant correlation with recurrence-free survival rate (p = 0.021). No patients had major complications during follow-up. Conclusions BAE is a safe and effective treatment to manage non-massive hemoptysis. The procedure may offer a better long-term control of recurrent hemoptysis and quality of life than conservative therapy alone. |
| first_indexed | 2024-12-19T02:10:18Z |
| format | Article |
| id | doaj.art-3550b8b277224acb80baa6fbd1616bf2 |
| institution | Directory Open Access Journal |
| issn | 1465-993X |
| language | English |
| last_indexed | 2024-12-19T02:10:18Z |
| publishDate | 2021-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Respiratory Research |
| spelling | doaj.art-3550b8b277224acb80baa6fbd1616bf22022-12-21T20:40:49ZengBMCRespiratory Research1465-993X2021-08-012211910.1186/s12931-021-01820-xFeasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysisJung Han Hwang0Jeong Ho Kim1Suyoung Park2Ki Hyun Lee3So Hyun Park4Department of Radiology, Gil Medical Center, Gachon University College of MedicineDepartment of Radiology, Gil Medical Center, Gachon University College of MedicineDepartment of Radiology, Gil Medical Center, Gachon University College of MedicineDepartment of Radiology, Gil Medical Center, Gachon University College of MedicineDepartment of Radiology, Gil Medical Center, Gachon University College of MedicineAbstract Purpose To evaluate the safety, efficacy, and long-term outcome of bronchial artery embolization (BAE) in the treatment of non-massive hemoptysis and the prognostic factors associated with recurrent bleeding. Materials and methods From March 2005 to September 2014, BAE was performed in 233 patients with non-massive hemoptysis. All patients had a history of persistent or recurrent hemoptysis despite conservative medical treatment. We assessed the technical and clinical success, recurrence, prognostic factors related to recurrent bleeding, recurrence-free survival rate, additional treatment, and major complications in all the patients. Results Technical success was achieved in 224 patients (96.1%), and clinical success was obtained in 219 (94.0%) of the 233 patients. In addition, 64 patients (27.5%) presented hemoptysis recurrence with median time of 197 days after embolization. Tuberculosis sequelae and presence of aberrant bronchial artery or non-bronchial systemic collaterals were significantly related to recurrent bleeding (p < 0.05). The use of Histoacryl-based embolic materials significantly reduced the recurrent bleeding rate (p < 0.05). Patient who had a tuberculosis sequelae showed a significantly lower recurrence-free survival rate (p = 0.013). Presence of aberrant bronchial artery or non-bronchial systemic collaterals showed a statistically significant correlation with recurrence-free survival rate (p = 0.021). No patients had major complications during follow-up. Conclusions BAE is a safe and effective treatment to manage non-massive hemoptysis. The procedure may offer a better long-term control of recurrent hemoptysis and quality of life than conservative therapy alone.https://doi.org/10.1186/s12931-021-01820-xBronchial arteryEmbolizationHemoptysisContrast-enhanced CTBronchoscopy |
| spellingShingle | Jung Han Hwang Jeong Ho Kim Suyoung Park Ki Hyun Lee So Hyun Park Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis Respiratory Research Bronchial artery Embolization Hemoptysis Contrast-enhanced CT Bronchoscopy |
| title | Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis |
| title_full | Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis |
| title_fullStr | Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis |
| title_full_unstemmed | Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis |
| title_short | Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis |
| title_sort | feasibility and outcomes of bronchial artery embolization in patients with non massive hemoptysis |
| topic | Bronchial artery Embolization Hemoptysis Contrast-enhanced CT Bronchoscopy |
| url | https://doi.org/10.1186/s12931-021-01820-x |
| work_keys_str_mv | AT junghanhwang feasibilityandoutcomesofbronchialarteryembolizationinpatientswithnonmassivehemoptysis AT jeonghokim feasibilityandoutcomesofbronchialarteryembolizationinpatientswithnonmassivehemoptysis AT suyoungpark feasibilityandoutcomesofbronchialarteryembolizationinpatientswithnonmassivehemoptysis AT kihyunlee feasibilityandoutcomesofbronchialarteryembolizationinpatientswithnonmassivehemoptysis AT sohyunpark feasibilityandoutcomesofbronchialarteryembolizationinpatientswithnonmassivehemoptysis |